Andrew Hall
Chief Executive Officer at IMV INC.
Net worth: 12 $ as of 30/12/2023
Andrew Hall active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMV INC. | Director/Board Member | 31/12/2021 | - |
| Chief Executive Officer | 03/08/2021 | - | |
| Corporate Officer/Principal | 09/11/2020 | 03/08/2021 |
Career history of Andrew Hall
Former positions of Andrew Hall
| Companies | Position | Start | End |
|---|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
| CELGENE | Corporate Officer/Principal | - | - |
Training of Andrew Hall
| University of Melbourne | Undergraduate Degree |
| RMIT University | Graduate Degree |
Statistics
International
| United States | 3 |
| Australia | 3 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| IMV INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Andrew Hall
- Experience
